Company Filing History:
1 out of 1,343 
1 out of 49 Years Active: 2023-2025
Title: The Innovations of Markus Mohrs
Introduction
Markus Mohrs is an accomplished inventor based in Pleasantville, NY (US). He has made significant contributions to the field of biotechnology, particularly in the development of IL10 agonists. With a total of 2 patents, his work focuses on improving therapeutic efficacy in anti-tumor treatments.
Latest Patents
Mohrs' latest patents include innovative IL10 agonists and methods of use thereof. The present disclosure relates to IL10 agonists that demonstrate improved anti-tumor therapeutic efficacy. Certain IL10 agonists disclosed in his patents comprise an IgG Fc domain, a linker moiety, and an IL10 moiety. These advancements hold promise for enhancing treatment options for patients battling tumors.
Career Highlights
Throughout his career, Markus Mohrs has worked with notable companies, including Regeneron Pharmaceuticals, Inc. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Jie Dai and Maria Del Pilar Molina-Portela. Their collaborative efforts have furthered the development of innovative solutions in the biotechnology sector.
Conclusion
Markus Mohrs exemplifies the spirit of innovation in biotechnology through his patents and collaborations. His work on IL10 agonists is paving the way for more effective anti-tumor therapies.